Am Heart J
- RODRIGO ZONI C, Mukherjee D, Gulati M
Reconsidering Fibrinolysis in Selected Patients with Non-ST-Elevation Acute
Coronary Syndrome: A Hypothesis-Generating, Research-Based Framework.
Am Heart J. 2026 Jul 31:107548. doi: 10.1016/j.ahj.2026.107548.
- WONG JA, Conen D, Doumouras A, Van Reekum E, et al
Rationale, Design, and Experiences from the Vanguard Phase of the Bariatric
Surgery for the Reduction of Cardiovascular Events (BRAVE) Trial.
Am Heart J. 2026 Jul 25:107544. doi: 10.1016/j.ahj.2026.107544.
Am J Cardiol
- RODRIGUES FB, Machado MN, Bruetto RG, Maia LN, et al
Sixth-Generation Cardiac Troponin T and Clinical Decision-Making in Acute Chest
Pain: Toward an Integrated Approach.
Am J Cardiol. 2026;273:138-140.
- MURASATO Y, Higashi K, Sugino H, Arikawa M, et al
Chronic Kidney Disease Stage-Specific Risk and Clinical Presentation in Left Main
Coronary Intervention: Insights from the LM-JANHO Registry.
Am J Cardiol. 2026 Jul 31:S0002-9149(26)00488.
- VICHOS T, Strepkos D, Alexandrou M, Carvalho PEP, et al
Sex Differences in Clinical Outcomes after Bifurcation Percutaneous Coronary
Intervention: Findings from the PROGRESS-BIFURCATION Registry.
Am J Cardiol. 2026 Jul 30:S0002-9149(26)00487.
- FAIZAN MA, Rehman T, Humayun Z, Dandamudi M, et al
Sex Differences in Access-site and Clinical Outcomes Following Transradial
Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.
Am J Cardiol. 2026 Jul 28:S0002-9149(26)00477.
- KAUR H, Carvalho PEP, Strepkos D, Alexandrou M, et al
Impact of Proximal Optimization Technique in Provisional Bifurcation Percutaneous
Coronary Intervention: Insights from PROGRESS-BIFURCATION Registry.
Am J Cardiol. 2026 Jul 27:S0002-9149(26)00478.
Angiology
- YANG J, Yao W, Li L, Yue Y, et al
Arterial Stiffness and Physical Activity-Related Cardiovascular Risk: A Sex- and
Gender-Informed Perspective.
Angiology. 2026 Jul 27:33197261471991. doi: 10.1177/00033197261471991.
- DING Q, Zhang W, Tian N
Comment on: Evaluation of Cardiovascular Risk Scores and Their Association With
Vascular Structural Changes in Patients With Retinal Vein Occlusion.
Angiology. 2026 Jul 27:33197261474634. doi: 10.1177/00033197261474634.
- OYAMA Y, Ueki Y, Kuwahara K
Reply: Association Between Achilles Tendon Thickness as Assessed by Ultrasound
and Coronary Artery Disease Severity in Patients Undergoing Percutaneous Coronary
Intervention.
Angiology. 2026 Jul 28:33197261475809. doi: 10.1177/00033197261475809.
- TEBER MK, Aydin MZ
Bilateral Anterior Tragal Crease Is Associated With Coronary Revascularization in
Patients With Stable Angina Pectoris.
Angiology. 2026 Jul 28:33197261474644. doi: 10.1177/00033197261474644.
- ANG SP, Chia JE, Mukherjee D
Author Reply to Letter: Outcomes of Kidney Transplant Recipients Undergoing
Percutaneous Coronary Intervention.
Angiology. 2026 Jul 29:33197261473782. doi: 10.1177/00033197261473782.
- WANG Q, Chen D, Li T
Exploring the Potential Role of SLC25A25-AS1 in Acute Coronary Syndrome.
Angiology. 2026 Jul 29:33197261471988. doi: 10.1177/00033197261471988.
Arterioscler Thromb Vasc Biol
- ZOU J, Zhu D, Cheng X, Cheng K, et al
Bioengineering Approaches for Nanomedicine Delivery in Therapy of Myocardial
Infarction.
Arterioscler Thromb Vasc Biol. 2026 Jul 30. doi: 10.1161/ATVBAHA.126.324247.
Atherosclerosis
- GOULD KL, Johson NP
Quantitative PET coronary flow capacity and comprehensive management of chronic
CAD: Lessons from the randomized CENTURY trial.
Atherosclerosis. 2026;419:120831.
- REVAIAH PC, Vengrenyuk Y, Santosh VK, Karki M, et al
Serial OCT-based coronary physiology and plaque composition in vessels with
nonobstructive coronary lesions following intensive lipid-lowering therapy:
YELLOW III sub-study.
Atherosclerosis. 2026;419:120836.
- WANG W, Sun Y, Chang K, Zheng Z, et al
Therapeutic targets for atherosclerotic coronary artery disease: druggable
genome-wide Mendelian randomization analysis.
Atherosclerosis. 2026;419:120810.
BMJ
-
No-touch versus conventional vein in coronary artery bypass grafting: three year
follow-up of multicentre randomised PATENCY trial.
BMJ. 2026;394:e100400.
Can J Cardiol
- WANG J, Li C
Clarification of Methodological Considerations in Angio-IMR Prognosis after Acute
Myocardial Infarction.
Can J Cardiol. 2026 Jul 25:S0828-282X(26)01046.
Cardiovasc Res
- LE GOUGE K, Ashour D, Heinrichs M, Stys P, et al
A distinct T cell receptor signature associates with cardiac outcome in
myocardial infarction patients.
Cardiovasc Res. 2026 Jul 29:cvag162. doi: 10.1093.
Catheter Cardiovasc Interv
- NOORI M, Hougaard M, Maehara A, Troan J, et al
Multimodality Intravascular Imaging Guidance (NIRS-IVUS-OCT) Compared to
Angiography-Guided Percutaneous Coronary Intervention in Patients With Acute
Myocardial Infarction: The NIRVUS Trial.
Catheter Cardiovasc Interv. 2026 Jul 28. doi: 10.1002/ccd.70765.
Circ J
- KATO K, Yamamoto K, Miyakoda K, Tamura N, et al
Acute and Chronic Management of Spontaneous Coronary Artery Dissection.
Circ J. 2026;90:949-955.
- ABE K, Kitahara H, Tateishi K, Saito Y, et al
Prognostic Impact of Achilles Tendon Thickening After Percutaneous Coronary
Intervention Compared Between Acute and Chronic Coronary Syndromes.
Circ J. 2026;90:1107-1109.
- YAP NAL, Bourantas CV, Losdat S, Ng NYJ, et al
Comparison of Atheroma Burden Changes Using Conventional vs. End-Diastolic
Intravascular Ultrasound Segmentation?- Post Hoc Analysis of the PACMAN-AMI
Study.
Circ J. 2026;90:1010-1021.
- KANAJI Y, Yamaji K, Kunimura A, Usui E, et al
Prognostic Impact of COVID-19 on Patients With Acute Coronary Syndrome Undergoing
Emergent Percutaneous Coronary Intervention?- Insights From the J-PCI Nationwide
Registry.
Circ J. 2026;90:1066-1075.
- ZHAI M, Bai F, Yan R, Liu M, et al
Monocyte Immunometabolic Axis Linking Type 2 Diabetes to Coronary Artery Disease
Revealed by Multi-Omics Integration and Mendelian Randomization.
Circ J. 2026;90:1076-1088.
- NISHINO M, Egami Y, Nohara H, Kawanami S, et al
Assessment of and Factors Contributing to Adequate Endothelization After
Drug-Eluting Stent Implantation.
Circ J. 2026;90:956-965.
- TANIGUCHI M, Taruya A, Kitahara C, Ota S, et al
Cathelicidin Links Visceral Fat Accumulation and Coronary Artery Disease.
Circ J. 2026;90:1089-1099.
- ITO T, Yokoi M, Kitada S, Kawada Y, et al
Time-Dependent Analysis of Blood Sampling to Detect Metabolic Ischemia?- Serial
Coronary Artery-Coronary Sinus Lactate Analysis During Acetylcholine Provocation.
Circ J. 2026;90:1110-1112.
- KOBA S, Yokota Y, Satoh N, Ito Y, et al
Small Dense Low-Density Lipoprotein Cholesterol Predicts Long-Term Coronary
Artery Disease Recurrence in Patients Without Metabolic Dyslipidemia.
Circ J. 2026;90:999-1009.
- EOM J, Kang DO, Nam HS, Lee W, et al
Lesion-Specific Prediction of Segmental Fractional Flow Reserve Using Deep
Learning and Optical Coherence Tomography-Derived Features.
Circ J. 2026;90:1025-1032.
- KAKIMOTO Y, Natsuaki M, Node K, Otake H, et al
Clinical Outcomes After Drug-Eluting Stent Thrombosis in Patients on
Hemodialysis?- Insights From the REAL-ST Registry.
Circ J. 2026;90:969-977.
- SABER QAYED K, Lien CW, Wang J, Kao HL, et al
Efficacy of Primary Retrograde Approach in Complex Chronic Total Occlusions With
Unfavorable Antegrade Characteristics and Feasible Interventional Collaterals.
Circ J. 2026;90:978-987.
- ZHANG D, Yi B, He L, Xu Y, et al
Non-Culprit Lesion Plaque Vulnerability Progression and Regression Assessed by
Serial Optical Coherence Tomography Imaging.
Circ J. 2026;90:1033-1043.
Circ Res
- BINEK A, Angel PM
Single Cell Proteomics to Spatial Multiomics in Cardiovascular Disease:
Foundations, Technologies, and Biological Insights.
Circ Res. 2026;139:e327684.
- YAN X, Zhang H, Fan Q, Hu J, et al
Correction to: Dectin-2 Deficiency Modulates Th1 Differentiation and Improves
Wound Healing After Myocardial Infarction.
Circ Res. 2026;139:e000763.
- PARKER SJ, Van Eyk JE
Defining Actionable Cell States in Cardiovascular Disease Through Single-Cell and
Spatial Technologies.
Circ Res. 2026;139:e329382.
- MA M, Lian Y, Shang E, Xue C, et al
Decoding Cardiovascular Disease Through Spatial Proteomics.
Circ Res. 2026;139:e327475.
Circulation
- VERGHESE D, Trujillo R, Abraham D, McClelland RL, et al
Predictive Value of Coronary Artery Calcium Score From Nongated Chest CT Scans
Compared With Gated Scans and Incidence of Cardiovascular Events.
Circulation. 2026;154:302-312.
- NDUMELE CE, Rangaswami J, Rodriguez F
Cardiovascular-Kidney-Metabolic Syndrome: A User's Guide to the Guidelines.
Circulation. 2026;154:409-412.
- POWELL-WILEY TM, Williams M, Davis EM
Telehealth for Community-Engaged Cardiovascular Care in Rural Populations.
Circulation. 2026;154:400-404.
- HUFFMAN MD, Vijay A, Mahmoud Z
2026 Cardiovascular-Kidney-Metabolic Guidelines: Practical Implementation
Strategies.
Circulation. 2026;154:413-415.
- LLOYD-JONES DM
Cardiovascular-Kidney-Metabolic Syndrome: A Historic Perspective.
Circulation. 2026;154:416-419.
- GANESH A, Sujanthan S, Muir RT, Joundi RA, et al
Major Adverse Cognitive Events (MACE-Cog): A New "MACE" Framework for Cognitive
Outcomes in Cardiovascular Diseases and Stroke.
Circulation. 2026;154:378-394.
- RODRIGUEZ F, Langlotz CP
Opportunistic Coronary Artery Calcium Screening: Time for Clinical
Implementation.
Circulation. 2026;154:313-315.
- BREWER LC, Joseph JJ, Cooper LA
Cardiovascular-Kidney-Metabolic Syndrome: Population and Policy Implications:
2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and
Management of Cardiovascular-Kidney-Metabolic Syndrome.
Circulation. 2026;154:405-408.
- STEINHAUSER ML
Translational Cardiovascular Science for the Circulation Community.
Circulation. 2026;154:299-300.
Clin Cardiol
- MURTAZA M, Rasool MM, Ali SME, Farhan M, et al
National Trends & Disparities in Ischemic Heart Disease & Cardiac Arrhythmias
Related Mortality in the United States From 1999 to 2024: A CDC Wonder Analysis.
Clin Cardiol. 2026;49:e70427.
- ZAHRAN A, Amer S, Bdair M, Hameedi S, et al
The Predictive Value of Platelet-to-Lymphocyte Ratio Before and After
Percutaneous Coronary Intervention in Patients With Acute ST-Segment Elevation
Myocardial Infarction: A Retrospective Cohort Study in Palestine.
Clin Cardiol. 2026;49:e70422.
- BAI Y, Liu C, Feng L
Comment on "Association of Ticagrelor Metabolic SNPs With Adverse Drug Reactions
in Patients With Acute Coronary Syndrome".
Clin Cardiol. 2026;49:e70428.
- WANG Q, Lei Y, Zhou Q, Long Y, et al
Dynamic Co-Evolution of Obesity-Metabolic-Inflammatory for Cardiovascular Disease
Risk Stratification in Middle-Aged and Older Adults: A Data-Driven Joint
Trajectory Analysis.
Clin Cardiol. 2026;49:e70429.
Int J Cardiol
- SIMIONI L, Loureiro T, Faucherre Y, Cioffi GM, et al
Impact of obesity on 1-year major adverse cardiac events after primary PCI for
STEMI.
Int J Cardiol. 2026 Jun 26:134644. doi: 10.1016/j.ijcard.2026.134644.
- SHIN ES, Kim S, Kang DO, Kim TH, et al
Clinical outcomes of intravascular imaging-guided versus angiography-guided
drug-coated balloon angioplasty for de novo coronary lesions.
Int J Cardiol. 2026;461:134663.
- RANASINGHE S, Tjoe B, Chang J, Cook-Wiens G, et al
Left ventricular end-diastolic pressure in women with ischemia and no obstructive
coronary artery disease: The women's ischemia syndrome evaluation - Coronary
microvascular dysfunction study (WISE-CVD).
Int J Cardiol. 2026;461:134672.
J Am Coll Cardiol
- MAZIDI M, Wright N, Pozarickij A, Millwood IY, et al
Cross-Ancestry Proteogenomic Analyses Identified New Therapeutic Insights for
Ischemic Heart Disease.
J Am Coll Cardiol. 2026 Jul 20:S0735-1097(26)06771.
- YOSHIJI S, Clarke SL
Triangulating Evidence in Proteome-Wide Mendelian Randomization for
Cardiovascular Disease: Insights Across Ancestries and Modalities.
J Am Coll Cardiol. 2026 Jun 30:S0735-1097(26)06764.
- WEN B, Wu Y, Lavigne E, Coelho M, et al
Compound Exposure to Extreme Heat and Substantial Landscape Fire-Sourced Air
Pollution on Cardiovascular Mortality.
J Am Coll Cardiol. 2026 Jul 19:S0735-1097(26)06772.
- CHU L
Heat Plus Fire: A Compound Hazard Threatening Cardiovascular Health.
J Am Coll Cardiol. 2026 Jul 16:S0735-1097(26)06836.
- KOLLIAS A, Krystallaki D, Tsaganos T
Lipoprotein(a) and Cardiovascular Risk Gradient Across Coronary Artery Calcium
Strata.
J Am Coll Cardiol. 2026 Jul 16:S0735-1097(26)06978.
- MARINACCI LX, Clinch K, Dar M, Prakash-Zawisza V, et al
Preventive Cardiovascular Care Delivery and Medicaid Accountable Care
Organizations: A Difference-in-Differences Analysis.
J Am Coll Cardiol. 2026 Jul 22:S0735-1097(26)06896.
- BHATIA HS, Fan Y, Wong ND
REPLY: Lipoprotein(a) and Cardiovascular Risk Gradient Across Coronary Artery
Calcium Strata.
J Am Coll Cardiol. 2026 Jul 22:S0735-1097(26)06977.
J Cardiovasc Pharmacol
- DE FILIPPO O, Bruno F, Giacobbe F, Beccuti G, et al
Incretin-based therapies, alcohol and tobacco use, and acute substance-related
events: emerging implications for cardiovascular medicine.
J Cardiovasc Pharmacol. 2026 Jul 28. doi: 10.1097/FJC.0000000000001862.
J Clin Endocrinol Metab
- ALUR-GUPTA S, DiTosto JD, Busse KR, Lewey J, et al
Manuscript Title: Social Determinants of Health and Cardiovascular Disease in
Women with Polyendocrine metabolic ovarian syndrome.
J Clin Endocrinol Metab. 2026 Jul 30:dgag308. doi: 10.1210.
J Thorac Cardiovasc Surg
- HWANG HY, Cho H, Sohn SH, Jang MJ, et al
Fifteen-year patency and 18-year clinical outcomes after surgical
revascularization using saphenous vein composite grafts to total arterial grafts.
J Thorac Cardiovasc Surg. 2026;172:369-378.
JAMA
- ANDERER S
Ischemic Heart Disease Deaths Increasingly Tied to BMI, Hyperglycemia.
JAMA. 2026 Jul 31. doi: 10.1001/jama.2026.9497.
Lancet
- RUEL M, Nambala S, Guo MH, Verevkin A, et al
Multivessel coronary artery bypass grafting via small thoracotomy versus
sternotomy (MIST): an investigator-initiated, international, open-label,
randomised controlled trial.
Lancet. 2026 Jul 31:S0140-6736(26)01288-2. doi: 10.1016/S0140-6736(26)01288.
N Engl J Med
- SKEITH L, Bates SM
Sex Hormone Influences on Cardiovascular Risk. Reply.
N Engl J Med. 2026;395:10.
- BONNET F, Vaduva P
Sex Hormone Influences on Cardiovascular Risk.
N Engl J Med. 2026;395:519-520.
- DOUXFILS J, Creinin MD, Foidart JM
Sex Hormone Influences on Cardiovascular Risk.
N Engl J Med. 2026;395:518-519.
- LEE YJ, Kim BK
LDL Cholesterol Targeting in Cardiovascular Disease. Reply.
N Engl J Med. 2026;395:516.
- CRAVEDI P, Ruggenenti PL, Remuzzi G
LDL Cholesterol Targeting in Cardiovascular Disease.
N Engl J Med. 2026;395:515-516.
- ZHU Q, Wang S
LDL Cholesterol Targeting in Cardiovascular Disease.
N Engl J Med. 2026;395:515.
- VAN TWIST DJL, Beeren J
LDL Cholesterol Targeting in Cardiovascular Disease.
N Engl J Med. 2026;395:514-515.
- HOWELL RR, Jones KW
LDL Cholesterol Targeting in Cardiovascular Disease.
N Engl J Med. 2026;395:514.
- MALLIDI J, Lotif A
LDL Cholesterol Targeting in Cardiovascular Disease.
N Engl J Med. 2026;395:513-514.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016